I was mistaken. He panned it at $3 and said it would never get approval. It ran up to $21 pretty quick. At $15 we got his famous words of oops.
Smith from last year - Yet the street needs to continue on
"Northwest Biotherapeutics has notified Feuerstein on numerous prior occasions that many of his statements on the phase 3 trial of DCVax-L were factually wrong. In each case, he has responded that the company was lying and fabricating data in order to manipulate the stock price. Feuerstein routinely ridiculed the Company’s explanation and actually stepped up attacks on NWBO.
The Chairman of the DMC has now made it abundantly clear that NWBO is totally blinded to the data and also that no interim efficacy analysis has been performed. These were lynchpin components of Feurstein’s allegation that the DCVax-L trial was doomed to fail. As most of us had previously concluded, he says that Feuerstein” lacks a fundamental understanding of clinical trial monitoring.”
The ongoing attacks on NWBO in Feuerstein in the 18 negative articles he has written over the last five months have had an enormously negative impact on the stock price and the credibility of management. It is now clear that Feuerstein’s allegations had no factual basis and were blatantly wrong. I would hope he would apologize to investors and set the record straight, but I don’t think that will happen. I am curious if he will try to refute the statements of the Chairman of the DMC."
You should stop the hype. Is this worth more? Probably and the same tired stuff from the street and others has no merit. Even the DMC went after AF last year over the same garbage. The DMC still has yet to do an efficacy analysis. Won't get efficacy on "L" phase III unless the DMC conducts it. That doesn't stop the Street with all their FUD.
I am afraid if you sell you will wake up one morning being left in the dust. Just accumulate where it looks good.
There will be nothing new today otherwise it would need to have been webcast or information put out in a PR for all investors. The next presentation we probably get the final data at ASCO.
They don't need it today but Sawston is being worked on. The original facilities and the added 13 acres. Why? They must be expecting something much bigger. Or else they are building condos. Sawston is going to be an enormous manufacturing facility.
I keep buying. It is typical nonsense. Relative to a valuation of KITE, the share should be 4 X higher.
Not that bad for me. I agree with you on our political class(especially the big Cs). LP hasn't lied or misled. We just need real answers about strategy. How this strategy that they have planned leads to X amount of $. They have done this planning and now I think it is time to have the shareholders involved with the strategy.
We have some very large shareholders at the top of the group. They own most of the company. Toucan, Cognate, Woodford, the billionaire and Powers are probably well over 85%. They have a great deal to gain with an increased share price. An open and public vision of the strategic planning would help. I believe Direct will very quickly become SOC. I know they have hinted about it but it is time to come clean.
That was the question to ask. How many have you treated in Germany. You said previously there was an extensive waiting list. How large is the waiting list? Are you treating them now without having compensation hashed out yet? Unfortunately, people submitted idiotic questions yesterday.
I don't need to hear about how the science works ever again. I want to know about Sawston. What will be manufactured there (Direct or L)? Who will it supply?
I want to know if they have been treating anyone in Germany while waiting for government pricing.
There is so much more to talk about and I want to talk about upcoming $$$$$$. It is business time. Development can continue but it is now time to talk $$$$$.
I do think this is the gateway for other cancer drugs. I am positive on the technology.
TIME TO TALK $$$$$! Aggravating to listen to each conference call.